Overview Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis Status: NOT_YET_RECRUITING Trial end date: 2027-02-01 Target enrollment: Participant gender: Summary This study is trying to evaluate the efficacy and safety of modified DEP regimens for the treatment of active hemophagocytic lymphohistiocytosis.Phase: PHASE4 Details Lead Sponsor: The First Affiliated Hospital of Soochow University